Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellectar Biosciences

0.2707
+0.00652.46%
Post-market: 0.2689-0.0018-0.66%17:05 EDT
Volume:1.22M
Turnover:320.13K
Market Cap:12.47M
PE:-0.19
High:0.2740
Open:0.2690
Low:0.2501
Close:0.2642
Loading ...
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 30, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Oct 17, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Oct 15, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Oct 08, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 30, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 24, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 16, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 10, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Sep 04, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Aug 26, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 20, 2019

Delisting

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Aug 15, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Aug 14, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Aug 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 09, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jun 28, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jun 14, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities